Clinical trial
A Randomised Controlled Trial Testing the Efficacy of the Treatment Strategy Observe-and-Plan Against Standard Treat-and-Extend in a Population of Newly Referred Patients With Age-related Macular Degeneration.
NCT04420923 is registered in ClinicalTrials.gov with St. Olavs Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised Controlled Trial Testing the Efficacy of the Treatment Strategy Observe-and-Plan Against Standard Treat-and-Extend in a Population of Newly Referred Patients With Age-related Macular Degeneration.
- Lead sponsor
- St. Olavs Hospital
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- May 20, 2020
- Completion date
- September 30, 2026
- Enrollment
- 250 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.